JP Morgan Private Capital, JP Morgan’s venture capital and growth equity investment team has held the final close of 270 Life Sciences Private Capital Fund I, above its $500m target.
LSPCF received commitments from institutional allocators, strategic corporate partners, family offices and HNWIs across North America, Europe, the Middle East and Asia, as well as JPMorgan Chase & Co. The fund close was led by CIO Stephen Squinto and Managing Partner Gaurav Gupta.
LSPCF invests in private biotechnology companies spanning cardiometabolic disease, oncology, immunology and genetic medicines.
Source:Private Equity Wire
Can’t stop reading? Read more
Missoni family passes baton as FSI takes control of €130m fashion house
Missoni family passes baton as FSI takes control of €130m fashion house FSI has become the...
Silver Lake-backed TKO launches $900m loan after $150m dividend
Silver Lake-backed TKO launches $900m loan after $150m dividend TKO Group Holdings, backed by...
Waterland targets cross-border growth with Palletways acquisition
Waterland targets cross-border growth with Palletways acquisition Waterland Private Equity has...
